Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2020 - Issue
Submit an article Journal homepage
161
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis

Henrik Watz1 Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, GermanyCorrespondence[email protected]
,
Kathleen Rickard2 Verona Pharma Plc, Raleigh, NC, USAORCID Iconhttps://orcid.org/0000-0002-2542-6011
ORCID Icon,
Tara Rheault2 Verona Pharma Plc, Raleigh, NC, USA
,
Thomas Bengtsson3 StatMind AB, Lund, Sweden
&
Dave Singh4 Medicines Evaluation Unit, University of Manchester & Manchester University NHS Foundation Trust, Manchester, UK
Pages 2199-2206 | Published online: 16 Sep 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

James F Donohue, Tara Rheault, Margot MacDonald-Berko, Thomas Bengtsson & Kathleen Rickard. (2023) Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1611-1622.
Read now
Clémence Martin, Pierre-Régis Burgel & Nicolas Roche. (2021) Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2363-2373.
Read now

Articles from other publishers (5)

Michael Troy, Joseph Van Vleet, Donald Tashkin & Igor Barjaktarevic. (2023) Recent advances predict a bright future for nebulizers. Current Opinion in Pulmonary Medicine 29:2, pages 123-132.
Crossref
Marco Mergiotti, Alessandra Murabito, Giulia Prono & Alessandra Ghigo. (2022) CFTR Modulator Therapy for Rare CFTR Mutants. Journal of Respiration 2:2, pages 59-76.
Crossref
Mario Cazzola, Clive Page & Maria Gabriella Matera. (2022) Ensifentrine: A First-in-class Bifunctional Drug for the Treatment of Chronic Obstructive Pulmonary Disease. US Respiratory & Pulmonary Diseases 7:2, pages 48.
Crossref
Peter J. Barnes. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine 729 740 .
Paul Zarogoulidis, Christoforos Kosmidis, Nikolaos Kougkas, Aimilios Lallas, Dimitris Petridis, Wolfgang Hohenforst-Schmidt, Haidong Huang, Lutz Freitag & Chrisanthi Sardeli. (2021) Modification of Apremilast from Pills to Aerosol a Future Concept. International Journal of Environmental Research and Public Health 18:21, pages 11590.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.